We are a Mexican company focused on pharmaceutical innovations by investing in the development of new medications, innovative pharmaceutical forms and therapeutic indications, achieving business partnerships with both domestic and international drug product manufacturers.
We are equipped to provide high-quality international business development, the importation and exportation of drug products and perform searches for suppliers and raw materials for regulated markets.
Our team is always in the search of new products and suppliers, exploring new territories with the intention of supplying the mexican market with highly specialized drug products.
To provide drug products of excellent quality to both public and private mexican markets that require these products at any given moment.
Establishing a unique and long lasting relationship with our commercial associates that allows us to culminate all our projects in a successful manner.
To be the leading company in Mexico by importing technology from industrialized countries, allowing us to make cutting-edge, high quality products accessible to patients and health institutions.
Our main objective is the health and well-being of every patient.
We continuously look for ways to improve our actions, projects, products and our day to day activities.
Passion to constantly search for new business opportunities.
We have the demanding spirit that seeks to break paradigms and challenges us every day to accomplish our objectives.
The mexican pharmaceutical market is currently in a period of rapid evolution due to modifications in legal framework and operational policies. It consists mainly of two distinct segments, which operate independently.
The public institutions, whose demand mainly comprises of generic and mature technology and private institutions who are characterized by their use of commercial and innovative brands.
From 2011 to 2016, the market for generic drugs in Mexico had an annual growth of 2 digits.
We Currently have the 059 Standard, Cofepris in Mexico is the authority approved by OMS through OPS which allows other countries to have acceptance of Mexican registrations.
The annual consumption made by the mexican government in public health is $ 2.5 billion dollars.